We illustrate this by analyzing two wild-type (Brd4-directed) CC datasets obtained using a model of GBM derived from murine neocortical postnatal Day 1 astrocytes engineered with a combined loss of function for neurofibromin (NF1) and p53. This evidence concerns the gene TP53 and glioblastoma.